Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
EPALINGES, SWITZERLAND / ACCESSWIRE / August 31, 2022 / Mymetics Corporation (OTCQB:MYMX) a pioneer in the research and development of virosome based vaccines and immunotherapies against infectious an
AccesswireAug 31, 2022 02:05 ET